C Kozma

Summary

Publications

  1. ncbi Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results
    Wayne Macfadden
    Ortho McNeil Janssen Scientific Affairs, LLC, Titusville, NJ, USA
    BMC Psychiatry 11:167. 2011
  2. ncbi Resource utilization in patients with schizophrenia who initiated risperidone long-acting therapy: results from the Schizophrenia Outcomes Utilization Relapse and Clinical Evaluation (SOURCE)
    Concetta Crivera
    Janssen Scientific Affairs, LLC, Raritan, New Jersey, USA
    BMC Psychiatry 11:168. 2011
  3. ncbi Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium
    Tim Lambert
    Ortho McNeil Janssen Scientific Affairs, LLC, Titusville, NJ, USA
    Ann Gen Psychiatry 10:10. 2011
  4. ncbi Predicting hospital admission and discharge with symptom or function scores in patients with schizophrenia: pooled analysis of a clinical trial extension
    Chris M Kozma
    University of South Carolina, Columbia, SC, USA
    Ann Gen Psychiatry 9:24. 2010
  5. ncbi Economic benefit of a 1-day reduction in hospital stay for community-acquired pneumonia (CAP)
    C M Kozma
    University of South Carolina, Columbia, SC, USA
    J Med Econ 13:719-27. 2010
  6. ncbi Change in employment status over 52 weeks in patients with schizophrenia: an observational study
    C Kozma
    University of South Carolina, Columbia, SC, USA
    Curr Med Res Opin 27:327-33. 2011

Collaborators

  • Carla M Canuso
  • Concetta Crivera
  • Wayne Macfadden
  • Lian Mao
  • Cherilyn Desouza
  • Stephen C Rodriguez
  • Tim Lambert
  • Riad D Dirani
  • Joseph Peuskens
  • An Jacobs
  • Patrick Otten
  • Riad Dirani
  • Jose M Olivares
  • Kasem S Akhras

Detail Information

Publications6

  1. ncbi Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results
    Wayne Macfadden
    Ortho McNeil Janssen Scientific Affairs, LLC, Titusville, NJ, USA
    BMC Psychiatry 11:167. 2011
    ..To evaluate effectiveness outcomes in a real-world setting in patients with schizophrenia initiating risperidone long-acting therapy (RLAT)...
  2. ncbi Resource utilization in patients with schizophrenia who initiated risperidone long-acting therapy: results from the Schizophrenia Outcomes Utilization Relapse and Clinical Evaluation (SOURCE)
    Concetta Crivera
    Janssen Scientific Affairs, LLC, Raritan, New Jersey, USA
    BMC Psychiatry 11:168. 2011
    ..This analysis examined health care resource utilization from a 24-month observational study of patients with schizophrenia initiated on risperidone long-acting therapy (RLAT)...
  3. ncbi Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium
    Tim Lambert
    Ortho McNeil Janssen Scientific Affairs, LLC, Titusville, NJ, USA
    Ann Gen Psychiatry 10:10. 2011
    ..abstract:..
  4. ncbi Predicting hospital admission and discharge with symptom or function scores in patients with schizophrenia: pooled analysis of a clinical trial extension
    Chris M Kozma
    University of South Carolina, Columbia, SC, USA
    Ann Gen Psychiatry 9:24. 2010
    ..The purpose of this analysis was to evaluate relationships between hospital admission or discharge and scores for symptom or functioning in patients with schizophrenia...
  5. ncbi Economic benefit of a 1-day reduction in hospital stay for community-acquired pneumonia (CAP)
    C M Kozma
    University of South Carolina, Columbia, SC, USA
    J Med Econ 13:719-27. 2010
    ..The objective of this paper was to estimate the potential economic benefit of a reduction in inpatient hospital LOS for a common type of admission, community acquired pneumonia (CAP)...
  6. ncbi Change in employment status over 52 weeks in patients with schizophrenia: an observational study
    C Kozma
    University of South Carolina, Columbia, SC, USA
    Curr Med Res Opin 27:327-33. 2011
    ..The aim of this post-hoc analysis was to describe change in employment status over time in patients with schizophrenia...